Back to News
Market Impact: 0.25
Bausch + Lomb Announces European CE Mark Approval Of SeeLyra; To Seek Approvals Around The World
Source: Nasdaq
Healthcare & BiotechProduct LaunchesRegulation & LegislationTechnology & Innovation
Bausch + Lomb received European CE Mark approval for SeeLyra, its next-generation femtosecond laser. The product will launch on a limited basis in Europe in the coming months, with broader availability expected in 2027, supporting the company's ophthalmic surgical technology pipeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
BLCO0.65
More News
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- Meta announces $95 billion stock offering to fund AI expansion
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis
- Apple says it will replace iPhone Duo units showing screen problems
- USTR Greer tells EU that loan to Airbus threatens trade truce on aircraft financing
- Blackstone-backed AirTrunk secures $2.98 bln green loan for Sydney campus